We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Kenvue Inc (KVUE) USD0.01

Sell:$24.00 Buy:$24.50 Change: $0.01 (0.04%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Sell:$24.00
Buy:$24.50
Change: $0.01 (0.04%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Sell:$24.00
Buy:$24.50
Change: $0.01 (0.04%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Ex-dividend
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Contact details

Address:
199 Grandview Road
SKILLMAN
08558
United States
Telephone:
+1 (732) 5240400
Website:
https://www.kenvue.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
KVUE
ISIN:
US49177J1025
Market cap:
$45.59 billion
Shares in issue:
1.92 billion
Sector:
Personal Care Products
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Thibaut Mongon
    Chief Executive Officer, Director
  • Paul Ruh
    Chief Financial Officer
  • Carlton Lawson
    Group President, Europe, Middle East and Africa and Latin America
  • Jan Meurer
    Group President, North America
  • Bing Xie
    Group President, Asia Pacific
  • Meredith Stevens
    Chief Operations Officer
  • Luani Alvarado
    Chief People Officer
  • Bernardo Tavares
    Chief Technology and Data Officer
  • Caroline Tillett
    Chief Scientific Officer
  • Matthew Orlando
    General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.